We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.825 | 0.80 | 0.85 | 0.85 | 0.80 | 0.80 | 2,358,877 | 10:31:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.44 | 1.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/11/2017 15:15 | have we been tipped somewhere? | curlly | |
09/11/2017 15:10 | Full ask still being paid . | jakleeds | |
09/11/2017 14:42 | Relentless buying. These are going way higher imo | jakleeds | |
09/11/2017 14:15 | Breaking out. Chart looking very good. Great news yesterday, wait for people to cotton on to what's happening here ... | jakleeds | |
09/11/2017 10:21 | well ive finally joined the party and will look to build a decent position ahead of the trials. | shrewdmole | |
09/11/2017 09:25 | Anyone attend the investor presentation yesterday? From the look of trading this morning the company were very well received;0) | trotterstrading | |
09/11/2017 09:13 | Could well be time to start building up the bigger positions here. | someuwin | |
09/11/2017 09:06 | No dilution, so this share can go up quickly:) | ch1rp | |
09/11/2017 09:06 | That's better. These should be kissing goodbye to the previous high before the year is out imo . | jakleeds | |
08/11/2017 20:06 | Remember these are reformulated products so will have a fasttrack time to market compared to conventional Pharma. Seriously undervalued here IMV. | bdog51 | |
08/11/2017 20:01 | From the N4P RNS released on 25 SEP 2017 - "The net proceeds of the Placing ensure that the Company will be funded throughout 2017 and 2018. " So no placing required until 2019 at the earliest. | bdog51 | |
08/11/2017 19:06 | meanwhile the cash keeps burning awaywhy don't someone ask nige how long these "multi billion" products are going to take to get to market?There's a decent size placing coming here at some point. that's what the market can see and why no one is buying the story. | backtogo | |
08/11/2017 08:14 | When are the 2 further Nuvac trials scheduled for, any ideas? | trotterstrading | |
08/11/2017 07:44 | The value of the global nanotechnology drug delivery market is forecast to grow from $4.1 billion in 2014 to $11.9 billion in 2023*. As nuvec(R) continues to meet its technical targets, it becomes very clear that we have the potential to become a significant player in this growing market. We will continue its development to determine how best to compete and to take the technology forward." | jakleeds | |
08/11/2017 07:19 | Access to a 4.1 billion market with a Mcap of only 4.25 million. Tiny free float, due to Nigel and others taking large quantities. Sit tight. A little bit of patience will deliver spectacularly | kingkongtimmo | |
07/11/2017 14:43 | yep, last couple of days i have seen more buys and a lower share price Good old AIM | zebbo | |
07/11/2017 11:46 | How come 75 000 shares bought and 63 000 sold adds up to over 4% down???? | ch1rp | |
01/11/2017 16:15 | An unacceptable share price performance | escapetohome | |
01/11/2017 16:05 | back to 5.25 tomorrow then! | whl2 | |
01/11/2017 08:58 | This must have bottomed out. With news, triple its value and beyond:) | ch1rp | |
17/10/2017 16:30 | Not exactly rocketing jakleeds, will be back down to 6p tomorrow knowing the mm's | whl2 | |
17/10/2017 15:54 | N4 Pharma have joined the line up for our next London seminar on the 8th November: Join us for presentations and a chance to ask questions to management. | sharesoc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions